Hot Takes Exchange: Stroke Prevention in 2030 Will Mostly Be: LAAO vs. Pill-in-the-pocket Anticoagulation

Name: Hot Takes Exchange: Stroke Prevention in 2030 Will Mostly Be: LAAO vs. Pill-in-the-pocket Anticoagulation
Start: 2026-09-19 10:25:00
End: 2026-09-19 10:45:00

September 19, 2026 | 10:25 AM (EDT) - 10:45 AM (EDT)

Share This event

Speakers

Christopher Ellis

Director LAA (Left Atrial Appendage) Program | Director AF Center

Vanderbilt University Medical Center

Peter J. Zimetbaum

Associate Chief and Clinical Director, Cardiology Division | Richard and Susan Smith Professor of Cardiology

Beth Israel Deaconess Medical Center | Harvard Medical School

Moderator

Kenneth Ellenbogen

Director of Clinical Cardiac Electrophysiology and Pacing | Kimmerling Chair of Cardiology | President

Virginia Commonwealth University | Heart Rhythm Society

Hot Takes Exchange: Stroke Prevention in 2030 Will Mostly Be: LAAO vs. Pill-in-the-pocket Anticoagulation

Hyde Park

September 19, 2026 | 10:25 AM (EDT) - 10:45 AM (EDT)

Long gone are the days of vitamin K antagonists as the sole therapy for stroke prevention in persons with atrial fibrillation. How will new anticoagulants, intermittent approaches to anticoagulation, and LAAO change how we prvent stoke in the future? This debate will let two experts hash it out in an engaging exchange.